Fulcrum Therapeutics, Inc. (FULC) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adults Dosed with Pociredir (All Cohorts as of Data Cutoff) | 148.00 | FY2025-Q4 |
| Study Drug Adherence Rate (to Date in the 20 Milligram Dose Cohort) | 90.00 percent | FY2025-Q3 |
| Number of Participants in 12 Milligram Dose Cohort | 16.00 | FY2025-Q2 |
Back to FULC overview · FULC earnings · FULC holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.